Cargando…
Preclinical efficacy of maternal embryonic leucine-zipper kinase (MELK) inhibition in acute myeloid leukemia
Maternal embryonic leucine-zipper kinase (MELK), which was reported to be frequently up-regulated in various types of solid cancer, plays critical roles in formation and maintenance of cancer stem cells. However, little is known about the relevance of this kinase in hematologic malignancies. Here we...
Autores principales: | Alachkar, Houda, Mutonga, Martin B.G., Metzeler, Klaus H., Fulton, Noreen, Malnassy, Gregory, Herold, Tobias, Spiekermann, Karsten, Bohlander, Stefan K., Hiddemann, Wolfgang, Matsuo, Yo, Stock, Wendy, Nakamura, Yusuke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4323011/ https://www.ncbi.nlm.nih.gov/pubmed/25365263 |
Ejemplares similares
-
2193: Targeting MELK in acute lymphoblastic leukemia, new therapeutic approach
por: Alachkar, Houda, et al.
Publicado: (2018) -
Maternal embryonic leucine zipper kinase (MELK) regulates multipotent neural progenitor proliferation
por: Nakano, Ichiro, et al.
Publicado: (2005) -
Effective growth-suppressive activity of maternal embryonic leucine-zipper kinase (MELK) inhibitor against small cell lung cancer
por: Inoue, Hiroyuki, et al.
Publicado: (2016) -
Computational exploration of maternal embryonic leucine zipper kinase (MELK) as a cancer drug target
por: Makki Almansour, Nahlah
Publicado: (2022) -
Targeting Suppressor of Variegation 3-9 Homologue 2 (SUV39H2) in Acute Lymphoblastic Leukemia (ALL)()
por: Mutonga, Martin, et al.
Publicado: (2015)